stars 1 stars 2 stars 3

Veritas Bio, LLC. is a privately held biotechnology company focused on developing technologies to enable nucleic acid-based medicines, in gene therapy, RNA-based drugs such as RNAi, miRNA, mRNA vaccines and DNA-based vaccines. Veritas Bio's enabling technologies include: Novel enabling methods of delivery of RNAi, miRNA, mRNA and other RNA molecules in vivo. Technologies that allow manufacture of antibiotic free plasmids, with higher supercoil density and higher yields Veritas Bio LLC patent application for "In Vivo Delivery Of Double Stranded RNA To a Target Cell" PATENTS 12-23-2010 ?The invention encompasses methods of delivering nucleic acids, including dsRNA, to mammalian target cells in vivo via intercellular transfer, wherein the dsRNA is delivered to or expressed in a first... Veritas Bio LLC patent application for "MICROBIAL HOST-VECTOR COMPLEMENTATION SYSTEM" ?PATENTS 8-19-2010 ?This invention provides a host-vector complementation system, which permits selection of vector-carrying host cells, without requiring an antibiotic resistance gene.

Bio LLC Questions

The Bio LLC annual revenue was $1 million in 2026.

Bio LLC is based in Jupiter, Florida.

The NAICS codes for Bio LLC are [541, 5417, 54171, 54, 541713].

The SIC codes for Bio LLC are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users